146 related articles for article (PubMed ID: 32861280)
21. Mantle cell lymphoma lacking the t(11;14) translocation: a case report and brief review of the literature.
Hunt KE; Reichard KK; Wilson CS
J Clin Pathol; 2008 Jul; 61(7):869-70. PubMed ID: 18587018
[TBL] [Abstract][Full Text] [Related]
22. Blastoid and common variants of mantle cell lymphoma exhibit distinct immunophenotypic and interphase FISH features.
Parrens M; Belaud-Rotureau MA; Fitoussi O; Carerre N; Bouabdallah K; Marit G; Dubus P; de Mascarel A; Merlio JP
Histopathology; 2006 Mar; 48(4):353-62. PubMed ID: 16487357
[TBL] [Abstract][Full Text] [Related]
23. Histone deacetylase inhibitor abexinostat affects chromatin organization and gene transcription in normal B cells and in mantle cell lymphoma.
Markozashvili D; Pichugin A; Barat A; Camara-Clayette V; Vasilyeva NV; Lelièvre H; Kraus-Berthier L; Depil S; Ribrag V; Vassetzky Y
Gene; 2016 Apr; 580(2):134-143. PubMed ID: 26774800
[TBL] [Abstract][Full Text] [Related]
24. Mantle cell lymphoma with a novel t(11;12)(q13;p11.2): a proposed alternative mechanism of CCND1 up-regulation.
Menke JR; Vasmatzis G; Murphy S; Yang L; Menke DM; Tun HW; King RL; Smoley SA; Ketterling RP; Sukov WR
Hum Pathol; 2017 Jun; 64():207-212. PubMed ID: 28132860
[TBL] [Abstract][Full Text] [Related]
25. Derivative (14)t(11;14)(q13;q32)t(11;14)(p11.2;p11.2): a novel unbalanced variant of the t(11;14)(q13;q32) translocation in mantle cell lymphoma.
Sathanoori M; Shekhter-Levin S; Marks SM; Swerdlow SH
Cancer Genet Cytogenet; 2007 Jan; 172(2):158-64. PubMed ID: 17213026
[TBL] [Abstract][Full Text] [Related]
26. Biology and management of mantle cell lymphoma.
Leonard JP; Schattner EJ; Coleman M
Curr Opin Oncol; 2001 Sep; 13(5):342-7. PubMed ID: 11555710
[TBL] [Abstract][Full Text] [Related]
27. A case of "double hit" mantle cell lymphoma carrying CCND1 and MYC translocations relapsed/refractory to rituximab bendamustine cytarabine (R-BAC) and ibrutinib.
Scapinello G; Riva M; Branca A; Pizzi M; Bonaldi L; Martines A; Manni S; Visentin A; Trentin L; Semenzato G; Gurrieri C; Piazza F
Ann Hematol; 2020 Nov; 99(11):2715-2717. PubMed ID: 32671454
[No Abstract] [Full Text] [Related]
28. Cyclin D1-negative mantle cell lymphoma with cryptic t(12;14)(p13;q32) and cyclin D2 overexpression.
Herens C; Lambert F; Quintanilla-Martinez L; Bisig B; Deusings C; de Leval L
Blood; 2008 Feb; 111(3):1745-6. PubMed ID: 18223179
[No Abstract] [Full Text] [Related]
29. Mantle cell lymphoma arising within primary nodal marginal zone lymphoma: a unique presentation of two uncommon B-cell lymphoproliferative disorders.
Rodig SJ; Healey BM; Pinkus GS; Kuo FC; Dal Cin P; Kutok JL
Cancer Genet Cytogenet; 2006 Nov; 171(1):44-51. PubMed ID: 17074590
[TBL] [Abstract][Full Text] [Related]
30. Mantle cell lymphoma.
Bertoni F; Zucca E; Cavalli F
Curr Opin Hematol; 2004 Nov; 11(6):411-8. PubMed ID: 15548996
[TBL] [Abstract][Full Text] [Related]
31. Mantle cell lymphoma mainly involving thoracic lesions: two case reports.
Kosaka M; Koizumi T; Fukushima T; Wada Y; Agatsuma T; Yokoyama T; Kanda S; Kubo K; Shimojo H; Horie S; Asano N
Intern Med; 2011; 50(14):1477-81. PubMed ID: 21757833
[TBL] [Abstract][Full Text] [Related]
32. Significance of cyclin D1 overexpression for the diagnosis of mantle cell lymphoma: a clinicopathologic comparison of cyclin D1-positive MCL and cyclin D1-negative MCL-like B-cell lymphoma.
Yatabe Y; Suzuki R; Tobinai K; Matsuno Y; Ichinohasama R; Okamoto M; Yamaguchi M; Tamaru J; Uike N; Hashimoto Y; Morishima Y; Suchi T; Seto M; Nakamura S
Blood; 2000 Apr; 95(7):2253-61. PubMed ID: 10733493
[TBL] [Abstract][Full Text] [Related]
33. Chronic lymphocytic leukemia with t(6;14) (p21;q32) CCND3-IGH: CCND3 rearrangement does not necessarily define a cyclin D1-negative mantle cell lymphoma.
Zhao Y; McCracken J; Rehder C; Wang E
Hematol Oncol; 2022 Feb; 40(1):111-114. PubMed ID: 34596253
[No Abstract] [Full Text] [Related]
34. A new multiple myeloma cell line, MEF-1, possesses cyclin D1 overexpression and the p53 mutation.
Yufu Y; Goto T; Choi I; Uike N; Kozuru M; Ohshima K; Taniguchi T; Motokura T; Yatabe Y; Nakamura S
Cancer; 1999 Apr; 85(8):1750-7. PubMed ID: 10223569
[TBL] [Abstract][Full Text] [Related]
35. A comparative analysis of FISH, RT-PCR, PCR, and immunohistochemistry for the diagnosis of mantle cell lymphomas.
Belaud-Rotureau MA; Parrens M; Dubus P; Garroste JC; de Mascarel A; Merlio JP
Mod Pathol; 2002 May; 15(5):517-25. PubMed ID: 12011256
[TBL] [Abstract][Full Text] [Related]
36. Detection of cyclin D1 overexpression by real-time reverse-transcriptase-mediated quantitative polymerase chain reaction for the diagnosis of mantle cell lymphoma.
Suzuki R; Takemura K; Tsutsumi M; Nakamura S; Hamajima N; Seto M
Am J Pathol; 2001 Aug; 159(2):425-9. PubMed ID: 11485900
[TBL] [Abstract][Full Text] [Related]
37. An aggressive B-cell lymphoma with rearrangements of MYC and CCND1 genes: a rare subtype of double-hit lymphoma.
Durot E; Patey M; Luquet I; Gaillard B; Kolb B; Delmer A
Leuk Lymphoma; 2013 Mar; 54(3):649-52. PubMed ID: 22784333
[No Abstract] [Full Text] [Related]
38. [Clinicopathologic feature of primary hepatic mantle cell lymphoma: report of a case].
Zhang ZK; Liu QR; Wu YQ; Hong CF; Li XX
Zhonghua Bing Li Xue Za Zhi; 2010 Jun; 39(6):418-20. PubMed ID: 21055164
[No Abstract] [Full Text] [Related]
39. Common consensus LNA probe for quantitative PCR assays in cancer: vehicles for minimal residual disease detection in t(11;14) and t(14;18) positive malignant lymphomas.
Sørensen CD; Jørgensen JM; Nederby L; Hokland P; Nyvold CG
J Immunol Methods; 2014 Apr; 406():131-6. PubMed ID: 24631717
[TBL] [Abstract][Full Text] [Related]
40. [Detection of cyclin D1 mRNA by reverse transcription-polymerase chain reaction in paraffin-embedded tissues and its diagnostic significance for mantle cell lymphoma].
Shui RH; Wei YK; Sun MH; Wang J; Shi DR; Zhang TM; Jin AP; Zhu XZ
Zhonghua Bing Li Xue Za Zhi; 2005 Aug; 34(8):514-8. PubMed ID: 16383299
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
